Dual role of the NF-κB transcription factor in the death of immature neurons

Neuroscience

Volumn 108, Issue 3, 2001, Pages 517-526

  Castagne V ^a   Lefevre K ^a   Clarke, P G H ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Development; Glutathione; Neuronal death; NF B; Protein synthesis; Transcription factors

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BUTHIONINE SULFOXIMINE; CYCLOHEXIMIDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGOPEPTIDE; PARTHENOLIDE; SALAZOSULFAPYRIDINE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; MODEL; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NERVE LESION; NEUROBLAST; NEUROPROTECTION; NONHUMAN; OPTIC TECTUM; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RETINA GANGLION CELL;

ANIMALS; AXOTOMY; BUTHIONINE SULFOXIMINE; CELL AGING; CELL DEATH; CHICK EMBRYO; CYCLOHEXIMIDE; EYE; GLUTATHIONE; INJECTIONS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-REL; RETINAL GANGLION CELLS; TISSUE DISTRIBUTION;

EID: 0035910188     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00430-4     Document Type: Article

References (80)

1. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
2. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
3. Oxidative stress and gene regulation
4. Gene expression and the thiol redox state
5. Apoptosis: Activate NF-κB or die?
6. The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation
7. 2+ accumulation
8. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor
9. Control of apoptosis by Rel/NF-κB transcription factors
10. In vitro antioxidant properties of potential biotransformation products of salicylate, sulphasalazine and amidopyrine
11. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB
12. Oxidative stress and nuclear factor-κB activation: A reassessment of the evidence in the light of recent discoveries
13. Programmed cell death in the developing nervous system
14. Protection of axotomized ganglion cells by salicylic acid
15. Axotomy-induced retinal ganglion cell death in development: Its timecourse and its diminution by antioxidants
16. Inhibition of glutathione synthesis can enhance cycloheximide-induced protection of developing neurons against axotomy
17. Cooperation between glutathione depletion and protein synthesis inhibition against naturally occuring neuronal death
18. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system
19. An optimal redox status for the survival of axotomized ganglion cells in the developing retina
20. Failure to activate NF-κB promotes apoptosis of retinal ganglion cells following optic nerve transection
21. Neuronal death during development in the isthmo-optic nucleus of the chick: Sustaining role of afferents from the tectum
22. Neuron death in vertebrate development: In vivo methods
23. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
24. Regulation of gene expression by reactive oxygen
25. The heat shock paradox: Does NF-κB determine cell fate?
26. Reduced nuclear factor kB (p65) expression in rat primary sensory neurons after peripheral nerve injury
27. Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
28. Redox regulation of NF-κB activation
29. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death
30. Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction
31. Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway
32. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
33. Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis
34. Inhibition of lipid peroxidation attenuates axotomy-induced apoptotic degeneration of facial motor neurons in neonatal rats
35. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β
36. Ganglion cell death during normal retinal development in the chick: Comparisons with cell death induced by early target field destruction
37. Influence of the cellular redox state on NF-κB-regulated gene expression
38. Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis
39. Brain synapses contain inducible forms of the transcription factor NF-κB
40. Constitutive NF-κB activity in neurons
41. NF-κB mediates the adaptation of human U937 cells to hydrogen peroxide
42. Inhibition of NF-κB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN)
43. Lucifer Yellow stains displaced amacrine cells of the chicken retina during embryonic development
44. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells
45. Is NF-κB the sensor of oxidative stress?
46. Glutathione depletion exacerbates impairment by oxidative stress of phosphoinositide hydrolysis, AP-1, and NF-κB activation by cholinergic stimulation
47. Thiol agents and Bcl-2 identify an αvirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB
48. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
49. Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons
50. Neuroprotection by dehydroepiandrosterone-sulfate: Role of an NFκB-like factor
51. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons
52. Roles of nuclear factor κB in neuronal survival and plasticity
53. Programmed cell life: Anti-apoptotic signaling and therapeutic strategies for neurodegenerative disorders
54. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration
55. c-Jun, JNK/SAPK kinases and transcription factor NF-κB are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis
56. NF-κB: A crucial transcription factor for glial and neuronal cell function
57. Activators and target genes of Rel/NF-κB transcription factors
58. Neuronal cell death
59. Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-κB and neuroprotection by antioxidants
60. Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine
61. Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
62. Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum
63. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis
64. Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: Effect on transcription factors AP-1 and NF-κB
65. NF-κB is activated and promotes cell death in focal cerebral ischemia
66. Assessing oxygen radicals as mediators in activation of inducible eukariotic transcription factor NF-κB
67. Potassium deprivation-induced apoptosis of cerebellar granule neurons: A sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species
68. Synergistic activation of NF-κB and inducible isoform of nitric oxide synthase induction by interferon-γ and tumor necrosis factor-α in INS-1 cells
69. Redox signaling and the emerging therapeutic potential of thiol antioxidants
70. Sulphasalazine: Mechanism of action in rheumatoid arthritis
71. Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family
72. Central nervous system DNA fragmentation induced by the inhibition of nuclear factor κB
73. Inhibition of nuclear factor κB (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
74. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons
75. Apoptosis in neurodegenerative diseases: The role of mitochondria
76. Signal transduction in neuronal death
77. Regulation of NF-kappaB, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappaB p50
78. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappaB
79. Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
80. Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury